Company Filing History:
Years Active: 2018
Title: The Innovations of Peter Shwonek
Introduction
Peter Shwonek is an accomplished inventor based in San Francisco, CA. He is known for his significant contributions to the field of pharmaceutical formulations, particularly in the development of methods that enhance the solubility and stability of peptide proteasome inhibitors.
Latest Patents
Peter Shwonek holds a patent for "Cyclodextrin complexation methods for formulating peptide proteasome inhibitors." This patent outlines methods for creating compositions that include one or more peptide proteasome inhibitors and a cyclodextrin, especially a substituted cyclodextrin. The methods described in this patent significantly improve the solubility and stability of these inhibitors, facilitating their manufacture and administration. For instance, homogeneous solutions of carfilzomib can be achieved at a pharmaceutically useful pH and at higher concentrations than previously possible without the use of cyclodextrins.
Career Highlights
Peter Shwonek is currently employed at Onyx Therapeutics, Inc., where he continues to innovate in the field of drug formulation. His work has been instrumental in advancing the development of effective treatments for various diseases.
Collaborations
Throughout his career, Peter has collaborated with notable colleagues, including Evan Lewis and Sean Dalziel. These partnerships have contributed to the successful development of his patented methods and formulations.
Conclusion
Peter Shwonek's innovative work in cyclodextrin complexation methods has made a significant impact on the formulation of peptide proteasome inhibitors. His contributions continue to advance the pharmaceutical industry and improve patient outcomes.